
The American Journal of Managed Care convened a panel of experts to discuss advances and challenges in treating multiple myeloma, which has seen longer survival rates since the arrival of bortezomib and thalidomide.
The American Journal of Managed Care convened a panel of experts to discuss advances and challenges in treating multiple myeloma, which has seen longer survival rates since the arrival of bortezomib and thalidomide.
A new study adds to the evidence that financial pressure, or the perception of pressure, may keep patients from getting treatment or taking medication for chronic conditions such as hypertension.
Two articles in Evidence-Based Diabetes Management examine the relationships among stress, diabetes and the brain, and the growing body of research into yoga's positive effects on reducing stress and improving health.
A study in The American Journal of Managed Care found that longer stays in hospice were associated with longer survival and lower end-of-life costs for patients with metastatic melanoma, a particularly deadly and increasingly common form of cancer.
In the new issue of Evidence-Based Oncology, Ellen T. Matloff, MS, CGC, and Rachel E. Barnett, MS, CGC, of the Yale Cancer Center and Robert Nussbaum, MD, of UC San Francisco write that efforts by some genetic testing laboratories to grab market share in the lucrative BRCA testing market may put patients at risk, while violating ethical standards issued by the American Medical Association.
The American Journal of Managed Care will host the first gathering of its ACO and Emerging Healthcare Delivery Coalition this week in Baltimore, Md. The ACO Coalition aims to share best practices for setting up successful ACOs.
Two leading academic rheumatologists who took part in a live discussion with A. Mark Fendrick, MD, co-editor-in-chief of The American Journal of Managed Care, agreed that getting an accurate early diagnosis of rheumatoid arthritis (RA) is key to getting the patient started on disease modifying therapy. Today's goal, they said, is remission of the disease, not just managing symptoms.
The American Journal of Managed Care publishes a first-of-its-kind study comparing different types of health insurance plans and different levels of co-payment, to see how varieties of coverage affect access to therapeutic drug classes.
Evidence-Based Immunology and Infectious Disease, the fourth title in the news series from The American Journal of Managed Care, launches with an issue that features interviews with leading AIDS researchers, a discussion of the challenges of paying for breakthrough therapies for hepatitis C, and new information on causes and treatments for rheumatoid arthritis.
What is the most important research tool in biology paid for by taxpayers that they don't know exists? It might be GenBank, the open-access database maintained by the National Institutes of Health, which allows scientists to dramatically reduce the time it takes to find druggable targets and identify genes in the evolution of personalized medicine.
Two new studies in The American Journal of Managed Care find that state Medicaid restrictions on access to newer antipsychotic drugs save little in the short run, and may cost more later when patients fail to stay on their medication, end up in the hospital, or both.
Julia Adler-Milstein, an assistant professor at the University of Michigan who has published extensively on the adoption of health information technology (HIT), will serve as guest editor for the annual issue of The American Journal of Managed Care devoted to HIT. The issue will publish in September 2014.
Ironman triathlete Jay Hewitt will speak tomorrow at the evening reception of Patient-Centered Diabetes Care: Putting Theory into Practice, which is bringing leaders in diabetes healthcare delivery to the Princeton Marriott at Forrestal. On Friday, Dr. Robert Gabbay, chief medical officer of the Joslin Diabetes Center, will offer a keynote address.
Use of a patient-centered medical home model to care for those with chronic illness reduced costs and trimmed utilization for high-risk patients, according to a three-year study published today in The American Journal of Managed Care
The American Journal of Accountable Care will be the media sponsor for a seminar set for March 27-28, 2014, at Innisbrook Golf and Spa Resort in Palm Harbor, Fla., sponsored by TripleAim ACO Consulting Group. TripleAim's mission for the event is to share how the 29 ACOs that experienced shared savings of $126 million in 2012 accomplished the task, and to guide newer ACOs to success.
Will Share Personal Account of Managing Condition at AJMC Event: Patient-Centered Diabetes Care: Putting Theory into Practice
AJMC Panel Touts Shift from 'Chronic' to 'Cured' as FDA Gives Breakthrough Status to BMS All-Oral Combo Regimen
How Can Molecular Diagnostic Companies Show Value if Insurers Won't Pay?
Oncology clinical pathways have helped health plans deliver quality care while keeping an eye on costs. The lack of standardization in pathways can be cumbersome on a busy oncology practice. If Medicare adopts a pathways model, it could offer a framework for broader use.
Can a diabetic's likelihood of developing complications depend on picking the right doctor? A study suggests it can.
Joslin's Dr. Robert Gabbay, USC's Dr. Geoffrey Joyce, and UnitedHealthcare's Dr. Deneen Vojta are among the lineup of national speakers coming to the Princeton Marriott at Forrestal April 10-11.
Dr. Robert Gabbay of Joslin Diabetes Center will offer the keynote address at Patient-Centered Diabetes Care 2014 on April 10-11 at the Princeton Marriott at Forrestal.
Breast cancer has the pink ribbon to promote mammograms. Colonoscopies saw a surge from the "Katie Couric effect" after the Today Show host had an an on-air exam following her husband's untimely death. But despite a USPSTF recommendation for lung cancer screenings for heavy smokers, there's a lack of awareness around the test, according to an expert who took part in a panel convened by The American Journal of Managed Care.
A large-scale study by Kaiser Permanente Southern California, published by AJMC, found that the more overweight the diabetic, the less controlled the patient's blood pressure and A1C level.
Are Doctors' Visits Set by Evidence or Habit? Extending Follow-ups Could Save Billions, Authors Say
MedImpact, a leading pharmacy benefit manager, will contribute the "Drug Trends" column for AJPB.
The recent dispute over the accuracy of the cardiovascular risk calculator points up the power and limitations of "big data," as well as the need for a blueprint for health guidelines aimed at consumers.
EBRC takes a special look at Smoking and Health, the 1964 report to the Surgeon General that forever changed how this country thought about cigarettes, on the eve of its 50th anniversary.
The coming year will be one for those who have beaten cancer to develop survivorship plans, with the Commission on Cancer to require planning by treatment centers starting in 2015.
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.